TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients

Psychopharmacology

Volumn 213, Issue 4, 2011, Pages 773-779

  Wang, Hsuan Chi ^a,c   Yeh, Tzung Lieh ^a   Chang, Hui Hua ^a   Gean, Po Wu ^a   Chi, Mei Hung ^b   Yang, Yen Kuang ^a   Lu, Ru Band ^a   Chen, Po See ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c TAINAN MUNICIPAL HOSPITAL   (Taiwan)

Author keywords

Antidepressant treatment response; Major depressive disorder; Tryptophan hydroxylase 1

Indexed keywords

FLUOXETINE; LORAZEPAM; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG; VENLAFAXINE;

ADD ON THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG RESPONSE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; TAIWAN; TREATMENT DURATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TAIWAN; TREATMENT OUTCOME; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 79952488880     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2034-1     Document Type: Article

References (38)

1. Anttila S, Huuhka K, Huuhka M, Rontu R, Mattila KM, Leinonen E, Lehtimaki T (2007) Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. J Neural Transm 114:461-468 (Pubitemid 46474865)
2. Bellivier F, Chaste P, Malafosse A (2004) Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 124B:87-91 (Pubitemid 38031599)
3. Chen C, Glatt SJ, Tsuang MT (2008) The tryptophan hydroxylase gene influences risk for bipolar disorder but not major depressive disorder: results of meta-analyses. Bipolar Disord 10:816-821
4. Du L, Bakish D, Hrdina PD (2001) Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord 65:37-44 (Pubitemid 32411570)
5. Evans J, Reeves B, Platt H, Leibenau A, Goldman D, Jefferson K, Nutt D (2000) Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med 30:1327-1334
6. Garriock HA, Hamilton SP (2009a) Genetic studies of drug response and side effects in the STAR*D study, part 1. J Clin Psychiatry 70:1186-1187
7. Garriock HA, Hamilton SP (2009b) Genetic studies of drug response and side effects in the STAR*D study, part 2. J Clin Psychiatry 70:1323-1325
8. Gizatullin R, Zaboli G, Jonsson EG, Asberg M, Leopardi R (2006) Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry 59:295-300 (Pubitemid 43238353)
9. Ham BJ, Lee MS, Lee HJ, Kang RH, Han CS, Choi MJ, Lee SH, Ryu SH (2005) No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population. Psychiatr Genet 15:299-301
10. Ham BJ, Lee BC, Paik JW, Kang RH, Choi MJ, Choi IG, Lee MS (2007) Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population. Prog Neuropsychopharmacol Biol Psychiatry 31:104-107
11. Harris EC, Barraclough B (1998) Excess mortality of mental disorder. Br J Psychiatry 173:11-53 (Pubitemid 28312203)
12. Illi A, Setala-Soikkeli E, Viikki M, Poutanen O, Huhtala H, Mononen N, Lehtimaki T, Leinonen E, Kampman O (2009) 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. NeuroReport 20:1125-1128
13. Jonsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, Owen MJ, Sedvall GC (1997) Tryptophan hydroxylase and catechol-O- methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247:297-302 (Pubitemid 28010679)
14. Judd LL, Schettler PJ, Solomon DA, Maser JD, Coryell W, Endicott J, Akiskal HS (2008) Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. J Affect Disord 108:49-58 (Pubitemid 351418013)
15. Kato M, Serretti A (2010) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15:473-500
16. Kato M, Wakeno M, Okugawa G, Fukuda T, Azuma J, Kinoshita T, Serretti A (2007) No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression. Neuropsychobiology 56:167-171 (Pubitemid 351567532)
17. Kraft JB, Slager SL, McGrath PJ, Hamilton SP (2005) Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58:374-381 (Pubitemid 41219705)
18. Li D, He L (2006) Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum Genet 119:233-240
19. Lin CH, Lin KS, Lin CY, Chen MC, Lane HY (2008) Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine. J Clin Psychiatry 69:54-59
20. Lin E, Chen PS (2008) Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics 9:935-946
21. Lin E, Chen PS, Chang HH, Gean PW, Tsai HC, Yang YK, Lu RB (2009) Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 33:1167-1172
22. Moncrieff J, Kirsch I (2005) Efficacy of antidepressants in adults. BMJ 331:155-157 (Pubitemid 41003178)
23. Nakamura K, Sugawara Y, Sawabe K, Ohashi A, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Nishimura H, Hasegawa H, Hirose S (2006) Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. J Neurosci 26:530-534 (Pubitemid 43237117)
24. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997) Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45:145-148 (Pubitemid 27182236)
25. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC, Goldman D, Linnoila M (1998) A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 55:593-602 (Pubitemid 28340346)
26. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP (2004) Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 9:879-889 (Pubitemid 39273536)
27. Rujescu D, Giegling I, Bondy B, Gietl A, Zill P, Moller HJ (2002) Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry 7:1023-1029 (Pubitemid 35333060)
28. Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA (2009) STAR*D: revising conventional wisdom. CNS Drugs 23:627-647
29. Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, Lilli R, Pirovano A, Catalano M, Smeraldi E (2003) SSRIs antidepressant activity is influenced by G beta three variants. Eur Neuropsychopharmacol 13:117-122 (Pubitemid 36313286)
30. Souery D, Van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, Del-Favero J, Dikeos D, Jakovljevic M, Kaneva R, Lattuada E, Lerer B, Lilli R, Milanova V, Muir W, Nothen M, Oruc L, Papadimitriou G, Propping P, Schulze T, Serretti A, Shapira B, Smeraldi E, Stefanis C, Thomson M, Van Broeckhoven C, Mendlewicz J (2001) Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry 49:405-409 (Pubitemid 32234302)
31. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157:1552-1562
32. Sun HS, Fann CS, Lane HY, Chang YT, Chang CJ, Liu YL, Cheng AT (2005) A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan. Alcohol Clin Exp Res 29:1-7 (Pubitemid 40129205)
33. Viikki M, Kampman O, Illi A, Setala-Soikkeli E, Anttila S, Huuhka M, Nuolivirta T, Poutanen O, Mononen N, Lehtimaki T, Leinonen E (2010) TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neurosci Lett 468:80-84
34. Walther DJ, Bader M (2003) A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66:1673-1680 (Pubitemid 37249312)
35. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76 (Pubitemid 36042402)
36. Yu YW, Tsai SJ, Liou YJ, Hong CJ, Chen TJ (2006) Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 16:498-503 (Pubitemid 44376554)
37. Zill P, Buttner A, Eisenmenger W, Moller HJ, Ackenheil M, Bondy B (2007) Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J Psychiatr Res 41:168-173 (Pubitemid 44708201)
38. Zill P, Buttner A, Eisenmenger W, Muller J, Moller HJ, Bondy B (2009) Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain. Neuroscience 159:1274-1282